Tango Therapeutics Payables and Accrued Expenses (Quarterly) Analysis

Tango Therapeutics, Inc. (TNGX)

16.95 +0.12 (+0.71%) USD | NASDAQ | Mar 06, 16:00

17.00 +0.05 (+0.29%) Pre-Market: 20:00

View Payables and Accrued Expenses (Quarterly) for TNGX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Payables and Accrued Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Payables and Accrued Expenses (Quarterly) Benchmarks

Start Trial

Recursion Pharmaceuticals, Inc.	Upgrade
Revolution Medicines, Inc.	Upgrade
AbbVie, Inc.	Upgrade
Kodiak Sciences, Inc.	Upgrade
Teleflex, Inc.	Upgrade